perforation in the lower third of the sigmoid colon in an area grossly thickened by muscular hypertrophy. A capsule of slow release indomethacin was lodged in the perforation, and five capsules were lying in the pouch of Douglas. Hartmann's procedure was performed, the abdomen was lavaged with copious saline, and she made an uneventful recovery.
Comment
Intestinal complications due to conventional formulations of indomethacin are rare.2 Lesions similar to those reported here have been produced in animals and appear to be reversible with the administration of prostaglandin E1, suggesting that inhibition of prostaglandin synthetase by indomethacin may be responsible.3
Indomethacin in a slow release capsule driven by an osmotic pump might be expected to be safer and more convenient. High concentrations of the drug may, however, build up on the mucosal surface if the capsule is halted in its passage. In our second patient it seems probable that the capsule lodged in a diverticulum, being rigid, adhesive, and of the right size and shape. Even in normal gastrointestinal tracts intestinal transit times vary widely,4 and indomethacin may itself alter intestinal motility and blood flow, resulting in the capsule being held up and mucosal clearance of the drug being delayed.5 Potassium bicarbonate is used as the osmotic driving agent. Potassium may cause small intestinal ulceration and its ulcerogenic effect may be exacerbated by concomitant indomethacin administration.
In both our patients the physical signs of peritonitis were masked. Physical signs in patients taking potent non-steroidal anti-inflammatory agents should be interpreted with the same degree of caution as in patients taking corticosteroids. Prostaglandins of the E series may be an effective antidote in future cases. Convulsions after self poisoning with zimeldine
Zimeldine is a new antidepressant that is chemically unrelated to the tricyclic and tetracyclic antidepressants. Information on its effects in acute overdosage in humans is scanty. We report on two patients in whom zimeldine overdosage caused grand mal convulsions.
Case reports
Case 1-A healthy 32 year old man was admitted to hospital four hours after ingesting about 2-5 g zimeldine and six pints of beer. He denied any specific complaints and was fully conscious with no neurological abnormalities. His pulse rate was 100 beats/minute and blood pressure 110/65 mm Hg. He refused gastric lavage, and emesis was induced with ipecac syrup. Four and a half hours after taking the tablets he had a generalised convulsion. Diazepam (5 mg) was given intravenously, and thereafter his recovery was uneventful.
Case 2-A 37 year old woman presented four hours after ingesting about 2 g zimeldine. She had not ingested any other drugs or alcohol. She had been treated with 100 mg zimeldine daily for several months for depression. The overdose made her feel sleepy, but on examination she was fully conscious and orientated. Fine jerk nystagmus was noted on lateral gaze, but she showed no other neurological abnormalities. Her pulse rate was 92 beats/minute and blood pressure 120/75 mm Hg. Gastric lavage was carried out, and five hours after ingestion she had a generalised convulsion lasting 45 seconds associated with incontinence of urine. No treatment was given, and her subsequent recovery was uneventful.
Neither patient had a personal or family history of epilepsy. On admission plasma electrolyte concentrations and results of liver function tests were normal. Electrocardiograms in both patients showed prominent U waves but were otherwise unremarkable. The figure shows serial plasma concentrations of zimeldine and norzimeldine, measured by gas liquid chromatography.' 
Comment
Zimeldine is a derivative of the antihistamine pheniramine and appears to act by selectively inhibiting uptake of serotonin (5-hydroxytryptamine) in the central nervous system. The demethylated metabolite, norzimeldine, is responsible for at least part of its pharmacological activity. Therapeutic doses seem to cause only minor anticholinergic effects,2 but attention has recently been drawn to serious adverse reactions including liver damage, neuropathies, and convulsions.3
Zimeldine overdosage in man has been reported on only three occasions. One patient with a family history of epilepsy had a convulsion after ingesting 1-7 g together with alcohol4; and drowsiness and vomiting were the only abnormalities noted in a patient who ingested 2-8 g zimeldine together with alcohol.' A third patient showed no toxic features after taking 1-75 g zimeldine together with dextropropoxyphene and alcohol.5
The maximum plasma zimeldine concentrations after a single dose of 200 mg are about 0-2-0 4 mg/l. The peak concentrations in our patients were at least 10 times higher, confirming substantial overdoses. Despite this, convulsions were the only complication noted.
The manufacturers are aware of 27 possible cases of zimeldine overdose, but most were not confirmed by laboratory analysis and other drugs were not excluded. Three patients had tremor or twitching, and two had convulsions, but coma seemed to develop only with concomitant ingestion of depressants of the central nervous system. One patient developed ventricular tachycardia, which could reasonably be attributed to thioridazine rather than zimeldine. Five patients regularly taking zimeldine and other drugs died outside hospital. Three had taken zimeldine overdoses, but the data are insufficient for death to be attributed to zimeldine alone. In the two other patients there was no evidence of an overdose of any drug. The limited reliable information available suggests that convulsions are the only serious complication of acute zimeldine overdosage.
[Sales of zimeldine in all countries were discontinued by Astra Pharmaceuticals in September 1983 because of the company's concern about reports of serious neurological side effects including the On examination, after roughly another 15 minutes, severe angio-oedema and pronounced erythema of the face, hands, and feet were found. She was fully conscious, her blood pressure was 85/50 mm Hg, and her radial pulse was weak and accelerated. She was treated with 2 mg clemastine fumarate intravenously, and within 15 minutes angio-oedema had diminished and blood pressure risen to 100/60 mm Hg. Treatment was continued with 50 mg mebhydrolin, and the following morning all symptoms had disappeared.
Besides an oral contraceptive she had not been taking any other drugs. She had never experienced an allergic reaction before except for the reported contact dermatitis to miconazole. CASE 2 A 52 year old man was prescribed ketoconazole 200 mg daily for dermatomycosis of the right foot (confirmed by direct microscopy). He took the first tablet at 1915. About half an hour later he noticed that his hands and feet had begun to swell and were itching severely. His general practitioner saw him at 2050. He was unrecognisable because of severe angio-oedema of his face, hands, and feet. He was vomiting and had pronounced dyspnoea, which resolved gradually. He was alert and had a normal radial pulse rate: blood pressure was not measured. The oedema had resolved about two hours after treatment with prednisolone 25 mg intravenously and mebhydrolin 50 mg.
He had never experienced an allergic reaction before and had not been taking any other drugs. As far as we know he had never been treated with antimycotic drugs and did not have contact with them at his work.
Both patients developed severe angio-oedema shortly after taking the first tablet of ketoconazole. Moreover, one patient developed frank anaphylactic shock, and the other experienced dyspnoea and vomiting.
Anaphylactic reactions to ketoconazole have not been reported before. Minor allergic reactions, such as rashes and urticaria, are reported sporadically; the incidence of rashes is about 1 %.' Seven cases of possible acute allergic reaction but none of anaphylactic shock to ketoconazole have been reported to the manufacturer (Janssen, Belgium), and 120 million tablets of ketoconazole have been distributed since clinical development started.
The first case is of particular interest because the patient had previously developed an allergy to miconazole. This drug is chemically related to ketoconazole, so apparently cross sensitivity between these drugs can occur. In the second patient no cause of sensitisation was evident, but possibly he had been exposed to related drugs in the past. These cases show that anaphylactic reactions to ketoconazole occur and that cross allergy with miconazole (and perhaps with other imidazoles) may exist. De novo minor status epilepticus of late onset presenting as stupor Minor status epilepticus1 occurring in patients with established epilepsy is well recognised, presenting as a confusional state without psychiatric symptoms.2 It has also been described occurring de novo in middle age.3 The clinical picture in these cases is variable: some patients show typical features of minor status epilepticus, and others present with a confusional state with psychotic symptoms but without stupor.4 Diagnosis of de novo status epilepticus of late onset may be delayed and initial treatment inappropriate because of this vatiability in presentation. We report a case of de novo minor status epilepticus of late onset presenting with stupor and subsequent psychotic features, which was followed by a postictal organic brain reaction.
Case report A 50 year old widow had become increasingly withdrawn, depressed, and confused over the 10 days before admission to hospital. She was admitted after being found mute by a friend. She had no history of epilepsy. Eighteen months previously she had developed an acute paranoid psychosis with auditory hallucinations and paranoid delusions after her husband's death. Electroencephalography was not performed on that occasion, and her psychosis had resolved over a week without specific treatment. Four months before admission she had been confused for three days but had recovered without medical attention.
On admission she was stuporous, did not respond to commands, and made no spontaneous movements. Her face was expressionless, and she showed waxy flexibility. Results of general and neurological examination were otherwise normal. Over the next few days she occasionally responded
